​

Funding Round

Series A - Arnatar Therapeutics

Series A - Arnatar Therapeutics

Investment Firm

Overview

Arnatar Therapeutics is a biopharmaceutical company that specializes in the development of novel nucleic acid medications.

Announced Date

Apr 08, 2024

Funding Type

Series A

Highlights

Location

United States, North America

Social

N/A

Investor Lead

Eight Roads Ventures

Eight Roads Ventures

Eight Roads Ventures is a early_stage_venture and late_stage_venture and venture firm.

3E Bioventures

3E Bioventures

3E Bioventures is a early_stage_venture and late_stage_venture firm.

Participant Investors

6

Investor Name
Participant InvestorYijing Capital
Participant Investor3E Bioventures
Participant InvestorLegend Star
Participant InvestorGaorong Capital
Participant InvestorEight Roads Ventures

Round Details and Background

Arnatar Therapeutics raised $50000000 on 2024-04-08 in Series A

Arnatar Therapeutics is a biopharmaceutical company that specializes in the development of novel nucleic acid medications.

Company Funding History

2

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Apr 08, 2024
Series A - Arnatar Therapeutics
8-50.0M
Sep 19, 2022
Seed Round - Arnatar Therapeutics
1-14.3M

Recent Activity

There is no recent news or activity for this profile.